Nuvo Pharmaceuticals Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada U.S. and International Rights to Vimovo

Nuvo Pharmaceuticals™ Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo

Nuvo Pharmaceuticals (TSX:NRI,OTCQB:NRIFF) has announced the filing of the business acquisition report on SEDAR related to an acquisition of a portfolio of more than 20 products and associated personnel and infrastructure to continue the products’ management and growth from Aralez Pharmaceuticals. As quoted in the press release: The BAR includes: Audited annual carve-out financial statements, … Continued

More From BioPortfolio on "Nuvo Pharmaceuticals™ Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo"